What is PAVmed Inc (PAVM) stock price today?

PAVmed Inc (PAVM) currently trades at $8.30 per share. The stock has a market capitalization of $61.09M and a P/E ratio of —x.

Is PAVM stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, PAVmed Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -15.29.

What is PAVmed Inc's revenue and earnings?

PAVmed Inc has trailing twelve-month (TTM) revenue of $71000.00 with profit margins of 565.00%. Earnings per share (EPS) is $-5.63.

Is PAVmed Inc financially healthy?

PAVmed Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -15.29 places it in the distress.

PAVM

PAVmed Inc

NASDAQ: PAVM · HEALTHCARE · MEDICAL DEVICES

$8.30

-6.95% today

Updated 2026-04-30

Market cap

$61.09M

P/E ratio

—

P/S ratio

860.44x

EPS (TTM)

$-5.63

Dividend yield

—

52W range

$6 – $25

Volume

0.0M

Market cap

$61.09M

P/E ratio

—

P/S ratio

860.44x

EPS (TTM)

$-5.63

Dividend yield

—

52W range

$6 – $25

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

4.0

Quality

4.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-15.3

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$40.50

+387.95%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Profit margin 565.00% — above average

+ Revenue growth 420.00% QoQ

+ Debt/equity 0.26x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -15.29 — distress zone

- Negative free cash flow $-6.39B

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$377000.00	$2.45M	$3.00M	$71000.00	$71000.00
Net income	$-88.98M	$-64.17M	$39.79M	$401000.00	$-1.26M
EPS	—	—	—	—	$-5.63
Free cash flow	$-72.53M	$-52.28M	$-33.61M	$-5.21B	$-6.39B
Profit margin	-23,602.92%	-2,617.25%	1,328.58%	564.79%	565.00%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PAVM	$61.09M	31	5.3	4.0	5.0	4.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

PAVmed Inc trades at $8.30. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -15.29, it sits in the distress. TTM revenue stands at $71000.00. with profit margins at 565.00%.

Frequently asked questions

What is PAVmed Inc's stock price?

PAVmed Inc (PAVM) trades at $8.30.

Is PAVmed Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of PAVmed Inc (PAVM)?

The analyst target price is $40.50, representing +388.0% upside from the current price of $8.30.

What is PAVmed Inc's revenue?

TTM revenue is $71000.00.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-15.29 — distress.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.pavmed.com

Quick metrics

P/S ratio860.44x

ROE-32.30%

Beta0.82

50D MA$9.77

200D MA$11.52

Shares out0.01B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PAVM vs LLY →PAVM vs JNJ →PAVM vs ABBV →Stock screener →